Literature DB >> 27453897

The Epigenetic Mechanisms of Amphetamine.

Talus J McCowan1, Archana Dhasarathy1, Lucia Carvelli1.   

Abstract

Amphetamine (AMPH) is a psychostimulant and the most prescribed drug to treat attention deficit hyperactive disorder (ADHD). Although therapeutically used doses are generally well tolerated, numerous side effects are still known to occur, such as jitteriness, loss of appetite and psychosis. Moreover, AMPH is liable to be abused by users looking for increased alertness, weight loss or athletic performance. A growing body of evidence indicates that drugs of abuse, including AMPH, control gene expression through chromatin modifications. However, while numerous studies have investigated the molecular mechanisms of AMPH action, only a small number of studies have explored changes in gene expression caused by AMPH. This review examines the epigenetic changes induced by chronic and acute treatments with AMPH and includes, where relevant, data obtained with other psychostimulants such as methamphetamine and cocaine.

Entities:  

Year:  2015        PMID: 27453897      PMCID: PMC4955852          DOI: 10.13188/2330-2178.S100001

Source DB:  PubMed          Journal:  J Addict Prev


  66 in total

Review 1.  The role of RNA interference in heterochromatic silencing.

Authors:  Zachary Lippman; Rob Martienssen
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

2.  Brain pattern of histone H3 phosphorylation after acute amphetamine administration: its relationship to brain c-fos induction is strongly dependent on the particular brain area.

Authors:  David Rotllant; Antonio Armario
Journal:  Neuropharmacology       Date:  2011-11-03       Impact factor: 5.250

Review 3.  New insights into the mechanism of action of amphetamines.

Authors:  Annette E Fleckenstein; Trent J Volz; Evan L Riddle; James W Gibb; Glen R Hanson
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

4.  Methamphetamine alters expression of DNA methyltransferase 1 mRNA in rat brain.

Authors:  Yohtaro Numachi; Haowey Shen; Sumiko Yoshida; Ko Fujiyama; Shigenobu Toda; Hiroo Matsuoka; Ichiro Sora; Mitsumoto Sato
Journal:  Neurosci Lett       Date:  2007-01-07       Impact factor: 3.046

5.  microRNAs miR-124, let-7d and miR-181a regulate cocaine-induced plasticity.

Authors:  Vijay Chandrasekar; Jean-Luc Dreyer
Journal:  Mol Cell Neurosci       Date:  2009-08-22       Impact factor: 4.314

6.  MeCP2 in the nucleus accumbens contributes to neural and behavioral responses to psychostimulants.

Authors:  Jie V Deng; Ramona M Rodriguiz; Ashley N Hutchinson; Il-Hwan Kim; William C Wetsel; Anne E West
Journal:  Nat Neurosci       Date:  2010-08-15       Impact factor: 24.884

7.  Regulation of gene expression and cocaine reward by CREB and DeltaFosB.

Authors:  Colleen A McClung; Eric J Nestler
Journal:  Nat Neurosci       Date:  2003-10-19       Impact factor: 24.884

Review 8.  Epigenetic mechanisms of drug addiction.

Authors:  Eric J Nestler
Journal:  Neuropharmacology       Date:  2013-04-30       Impact factor: 5.250

9.  Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates.

Authors:  Daniel Globisch; Martin Münzel; Markus Müller; Stylianos Michalakis; Mirko Wagner; Susanne Koch; Tobias Brückl; Martin Biel; Thomas Carell
Journal:  PLoS One       Date:  2010-12-23       Impact factor: 3.240

10.  Epigenetic inheritance of a cocaine-resistance phenotype.

Authors:  Fair M Vassoler; Samantha L White; Heath D Schmidt; Ghazaleh Sadri-Vakili; R Christopher Pierce
Journal:  Nat Neurosci       Date:  2012-12-16       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.